{
  "trial_id": "NCT00324155",
  "trial_group": "cancer",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, gender, ECOG performance status, HIV status, Hepatitis B status, Hepatitis C status, prior therapy, measurable disease status, lab results, imaging results.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "gender"
        ],
        [
          "Eastern Cooperative Oncology Group Performance Status",
          "ECOG performance status"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Male",
        "Region of Enrollment",
        "Melanoma Tumor Stage; Metastasis Classification at Study Entry"
      ],
      "remaining_candidate_features": [
        "HIV status",
        "Hepatitis B status",
        "Hepatitis C status",
        "prior therapy",
        "measurable disease status",
        "lab results",
        "imaging results"
      ]
    }
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, ECOG Performance Status, Measurable Disease Status, HIV Status, Hepatitis B Status, Hepatitis C Status, Prior Therapy,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Eastern Cooperative Oncology Group Performance Status",
          "ECOG Performance Status"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Region of Enrollment",
        "Melanoma Tumor Stage; Metastasis Classification at Study Entry"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Measurable Disease Status",
        "HIV Status",
        "Hepatitis B Status",
        "Hepatitis C Status",
        "Prior Therapy"
      ]
    }
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, ECOG Performance Status, Prior Adjuvant Therapy, Measurable Disease, HIV Status, Hepatitis B Status, Hepatitis C Status",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ],
        [
          "Eastern Cooperative Oncology Group Performance Status",
          "ECOG Performance Status"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Melanoma Tumor Stage; Metastasis Classification at Study Entry"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Prior Adjuvant Therapy",
        "Measurable Disease",
        "HIV Status",
        "Hepatitis B Status",
        "Hepatitis C Status"
      ]
    }
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, ECOG performance status, HIV status, Hepatitis B and C status, presence of brain metastasis, primary tumor location (ocular or mucosal), prior adjuvant therapy, measurable disease status, laboratory values (e.g. complete blood count, liver function tests).",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Eastern Cooperative Oncology Group Performance Status",
          "ECOG performance status"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Male",
        "Region of Enrollment",
        "Melanoma Tumor Stage; Metastasis Classification at Study Entry"
      ],
      "remaining_candidate_features": [
        "HIV status",
        "Hepatitis B and C status",
        "presence of brain metastasis",
        "primary tumor location (ocular or mucosal)",
        "prior adjuvant therapy",
        "measurable disease status",
        "laboratory values (e.g. complete blood count, liver function tests)"
      ]
    }
  }
}